BiotechTube
Home/Tryptamine Therapeutics/Robin Carhart-Harris, Ph.D.
RC

Robin Carhart-Harris, Ph.D.

Chairman, Scientific Advisory Board

Tryptamine Therapeutics

Therapeutic Areas

NeuropsychiatryPainGastroenterologyEating Disorders

Tryptamine Therapeutics Pipeline

DrugIndicationPhase
TRP-8803Fibromyalgia, IBS, Binge Eating Disorder, Depression, Pain, OCDPhase 1

Leadership Team at Tryptamine Therapeutics

DD
Dr. Daniel Tillett
Non‑Executive Director
HJ
Herwig Janssen
Chairman, Board
View full Tryptamine Therapeutics profile